Biden’s parting gift to Big Pharma will hammer GLP-1 patients — like me
This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide — ...
Healthcare Dive12d
In FDA job cuts, experts see threat of far-reaching impact
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...
USA Today11d
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Robert Califf, who was FDA commissioner under President Joe Biden, said he did not think the agency's declaration would necessarily end obesity drug compounding. "There so much money to be made.
Washington Examiner5d
RFK Jr. urged to halt Biden-era animal testing on cosmetics
Cory Booker (D-NJ) at the end of the Biden administration and now PETA President ... in latest flex of influence The plan before the FDA is to conduct animal testing, which has fallen out of ...
The Hill8d
Pfizer hires ex-FDA drug chief as top doctor
The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer ... when President Biden nominated him for the same job. Califf eventually made ethics concessions ...